JUNO THERAPEUTICS Trademark

Trademark Overview

On Monday, February 1, 2016, a trademark application was filed for JUNO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the JUNO THERAPEUTICS trademark a serial number of 86893723. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by Juno Therapeutics, Inc.. The JUNO THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific laboratory services, namely, processing blood to isolate lymphocytes for the creation of immunotherapies
juno therapeutics

General Information

Serial Number86893723
Word MarkJUNO THERAPEUTICS
Filing DateMonday, February 1, 2016
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6228219
Registration DateTuesday, December 22, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of the word "JUNO" appearing in stylized lower-case lettering above the word "THERAPEUTICS" appearing in smaller upper-case lettering, and with an abstract design of a star consisting of line and dashes radiating from the center above the letter "J".
Goods and ServicesScientific laboratory services, namely, processing blood to isolate lymphocytes for the creation of immunotherapies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code042
First Use Anywhere DateThursday, April 9, 2015
First Use In Commerce DateThursday, April 9, 2015

Trademark Owner History

Party NameJuno Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameJuno Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameJuno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 17, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 16, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 21, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 7, 2020USE AMENDMENT FILED
Tuesday, April 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 7, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, April 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 31, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, December 31, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 31, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, December 31, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2019NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2019NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, January 16, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, July 10, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 30, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 30, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 4, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 8, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 8, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 26, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 26, 2017ASSIGNED TO LIE
Thursday, December 8, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 8, 2016LETTER OF SUSPENSION E-MAILED
Thursday, December 8, 2016SUSPENSION LETTER WRITTEN
Friday, November 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2016NON-FINAL ACTION WRITTEN
Monday, May 16, 2016ASSIGNED TO EXAMINER
Saturday, February 6, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics juno isolate lymphocytes creation immunotherapies blood processing laboratory services namely scientific